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Long-Term Faithful Recapitulation of Transglutaminase
1–Deficient Lamellar Ichthyosis in a Skin-Humanized
Mouse Model, and Insights from Proteomic Studies
Transglutaminase 1 (TG1)–deficient la-
mellar ichthyosis (LI) is associated with
increased mortality in the neonatal
period and has a marked impact on
quality of life. No efficient treatment is
available; current therapy only relieves
some symptoms (Oji and Traupe,
2006). For the development of new
therapeutic approaches and to further
investigate molecular mechanisms un-
derlying the pathophysiology of LI, a
stable, long-lived preclinical model is
needed, which fully recapitulates the
human skin phenotype.
In vivo studies in human skin are
limited by ethical and practical consid-
erations. The Tgm1/ mouse does not
recapitulate the human skin phenotype.
Moreover, the mice die within the first
hours of life (Matsuki et al., 1998)
because of impaired barrier function,
underscoring the importance of TG1 for
barrier formation (Candi et al., 2005).
Only transplanted Tgm1–/– mouse skin
resembled the skin seen in severe
ichthyosis (Kuramoto et al., 2002). Cho-
ate and colleagues showed the feasibility
of ex vivo and in vivo gene transfer for LI
(Choate et al., 1996; Choate and Kha-
vari, 1997), although their model system
only allowed short-term human skin
regeneration. Moreover, a model of rat
skin with TG1 deficiency was described
(O’Shaughnessy et al., 2010).
Using optimized tissue engineering
and surgical conditions enabling stable
human skin engraftment in athymic nude
mice (Garcı´a et al., 2011), we have been
able to develop a robust skin-human-
ized mouse model for TG1-deficient
LI, involving persistent engraftment of
bioengineered human skin, suitable
for long-term, preclinical studies and
for the investigation of molecular me-
chanisms.
We analyzed two LI patients and
identified the compound heterozygous
TGM1 mutations c.377G4A (p.Arg
126His) and c.876þ 2T4C (p.Glu253
Valfs*2; patient 1) and c.428G4A
(p.Arg143His) and c.877-2A4G
(p.Phe293Serfs*38 or p.Phe293Valfs*2;
patient 2), which were previously de-
scribed (Farasat et al., 2009). Punch
biopsies obtained from these patients
were used to isolate keratinocytes and
fibroblasts after obtaining written, in-
formed consent of the probands and
institutional approval in accordance
with the Declaration of Helsinki Princi-
ples. At 4–6 weeks after grafting of
bioengineered skin equivalents, regen-
erated human skin grafts became visible
and persisted in the recipient animals
longer than 20 weeks, indicating stable
engraftment of epidermal stem cells
(data not shown).
Macroscopically, epidermal hyper-
plasia and an increased scaly hyperker-
atosis completely matched the human
skin phenotype. Using a human-speci-
fic antibody against involucrin, we
could confirm the human origin of the
grafts and clearly delineate the border
between mouse and human skin. Light
microscopy displays a very thick and
packed stratum corneum (SC) in the LI
grafts (Figure 1a).
TG1 activity and protein were absent
in LI skin/grafts. Ultrastructural analysis
revealed cholesterol clefts in the SC of
the LI skin/grafts, which are important
diagnostic markers typical for TG1
deficiency (Pigg et al., 1998). In contrast,
skin/grafts derived from healthy indivi-
duals were completely normal (Figure 1b).
The presence and spatial distribution
of TG1 substrates, differentiation mar-
kers, and dermoepidermal junction
(DEJ) constituents were assessed by
immunostaining. The comparison be-
tween normal graft/skin and LI graft/
skin showed that normal grafts mirrored
normal skin and, similarly, alterations
of epidermal differentiation in LI grafts
matched those found in LI skin. The
diffuse and upwardly shifted distribu-
tion of loricrin and involucrin indicates
insufficient cross-linking of these pro-
teins into the cornified envelope (CE).
Filaggrin was expressed in the periph-
ery of cells from the upper spinous layer
in all samples. The early differentiation
marker keratin 10, localized in viable
suprabasal cell layers, remained un-
changed (Figure 1c). Integrin-a6 dec-
orates the DEJ in a continuous, linear
manner. Collagen VII was present along
the DEJ, indicating its correct formation
in the grafts (Figure 1d).
To further explore changes in differ-
entiation and to relate them to the
previous results, we present, to our
knowledge previously unreported, data
on the analysis of the proteome of LI
epidermis. Comparison between normal
and LI skin/grafts provides valuable in-
sights into molecular mechanisms in-
volved in LI pathophysiology. Analysis of
the skin-humanized mouse model yields
very similar data to those observed in LI
skin. Altogether, 147 proteins were
identified (Supplementary Table S1 on-
line). We focused on TG1 substrates and
some conspicuous proteins, which may
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give insights into molecular differentia-
tion mechanisms (Table 1).
The numbers of unique peptides from
identified proteins in the grafts were
highly consistent with those found in
human skin biopsies. No TG1 peptides
could be detected in LI skin. The four
TG1 peptides detected in one of three LI
grafts (Table 1) were likely derived
from surrounding mouse tissue, as the
sequences are identical in mouse and
human.
Notably, the number of unique filag-
grin peptides decreased markedly in
both LI skin and grafts. Profilaggrin is
proteolytically processed during kerati-
nocyte differentiation and subsequently
degraded into hydrophilic amino acids,
their metabolites, and ions that contri-
bute to moisture retention in the SC.
Expression of filaggrin and its hydrolysis
into these natural moisturizing factors
(NMFs) are influenced by the SC micro-
environment, including local pH, exter-
nal humidity, and transepidermal water
loss (TEWL) (O’Regan et al., 2008). The
reduction of filaggrin detected by pro-
teome analysis in LI skin/grafts may be
attributed to an increased hydrolysis into
NMFs to compensate for TEWL.
In contrast, the number of unique
loricrin peptides increased in LI in
comparison with normal skin/grafts.
Loricrin becomes extensively cross-
linked to numerous CE components
by different TGs (Candi et al., 2005).
Insufficient intermolecular oligomeriza-
tion by TG1 could result in an enhanced
accessibility of trypsin cleavage sites
during sample processing, resulting in
an increase of unique peptides. Simi-
larly, a marked increase of unique
peptides of keratinocyte proline-rich
protein (KPRP) was found in LI skin/
grafts. KPRP expression was markedly
increased in psoriatic lesions, suggesting
that it could be extensively cross-linked
by TG1 like small proline-rich proteins
or some late CEs (Lee et al., 2005).
Interestingly, we did not observe
changes in the number of unique
peptides of involucrin, one of the first
proteins to be cross-linked to initiate CE
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Figure 1. Characterization of the skin-humanized mouse model for transglutaminase 1–deficient lamellar ichthyosis. (a) Keratinocytes were seeded onto a
fibroblast-populated fibrin-based matrix. Skin equivalents were grafted orthotopically onto the back of athymic nude mice. (i) Normal human regenerated skin
and (ii) regenerated lamellar ichthyosis (LI) skin (patient 1) 12 weeks after grafting; (iii) peroxidase staining of involucrin (human specific) confirms the
human skin phenotype; (iv) semithin sections, methylene blue staining, and morphology of normal and (v) LI grafts showing a very thick and packed stratum
corneum (SC). Bar: iv, v¼ 50mm. (b i–iv) Transglutaminase 1 (TG1) activity, (v–viii) TG1 protein, and (ix–xii) ultrastructure. Normal skin/grafts show the typical
pericellular distribution of TG1 activity/protein in the stratum granulosum. Ultrastructurally, no cholesterol clefts are visible. In contrast, LI skin and LI grafts
lacked TG1 activity/protein but displayed cholesterol clefts as typical ultrastructural markers. (c i–iv) Characterization of human and regenerated skin by
immunostaining. TG1 substrates such as loricrin (lor), (v–viii) involucrin (inv), and (ix–xii) filaggrin (flg) in LI samples show a more diffuse and slightly shifted
staining pattern when compared with the normal samples. (xiii–xvi) Keratin 10 (K10) was expressed in suprabasal layers in all four samples. (d i–iv) The
distributions of integrin-a6 (int-a6) and (v–viii) collagen VII (col VII) in LI skin/grafts in comparison with normal skin/grafts are visualized by immunostaining.
These components of the dermoepidermal junction show a comparable staining in all samples, indicating a correct formation of the junction zone. Slides were
counterstained with 40,6-diamidino-2-phenyl indole. CC, cholesterol clefts.
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layer adjacent to the cell membrane
(Candi et al., 2005). We speculate that
this location does not alter its accessi-
bility to trypsin.
Desmoplakin, a structural cytoskele-
ton constituent, which participates in
keratinocyte adhesion, and other des-
mosomal/corneodesmosomal proteins
such as desmoglein 1, desmocollin 1,
junction plakoglobin, and corneodes-
mosin display a marked increase in
unique peptide numbers in LI skin/
grafts. From a clinical perspective, it is
likely that increased expression of
desmosomal adhesion molecules re-
sults in increased ‘‘stickiness’’ of cor-
neocytes and thus explains why in LI
the scales are large and plate-like, as
normal, invisible desquamation did not
occur. The rigid adhesion of cells is
thought to be a compensatory effect to
prevent TEWL (Steinert et al., 1998).
We conclude that the LI skin-huma-
nized mouse model faithfully recapitu-
lates the human disease phenotype
and concomitant molecular changes
and can be used as an excellent tool
for testing new therapeutic approaches
for this up-to-now untreatable geno-
dermatosis.
The study was approved by the
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